RoryShallisMD

PubMed

• 19 citations
  Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Cons...
  Talha Badar, Ehab Atallah, Rory Shallis, Antoine N Saliba, Anand Patel
  Leukemia. 2023-04-01
• 16 citations
  Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review
  Rory M. Shallis, Rachel S. Rome, John L. Reagan
  Clinical Lymphoma, Myeloma & Leukemia. 2017-12-01
• Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions.
  Aram Bidikian, Jan P Bewersdorf, Rory M Shallis, Ted M Getz, Jessica M Stempel
  Expert Review of Anticancer Therapy. 2024-11-01

Abstracts/Posters

• The Impact of the 2011 European Leukemianet (ELN) Guidelines for Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms on Therapeutic Phlebotomy and ...
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Populati...
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United State...
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neopl...
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019